Cumulative meta-analysis of therapeutic trials for myocardial infarction - PubMed (original) (raw)
. 1992 Jul 23;327(4):248-54.
doi: 10.1056/NEJM199207233270406.
Affiliations
- PMID: 1614465
- DOI: 10.1056/NEJM199207233270406
Free article
Cumulative meta-analysis of therapeutic trials for myocardial infarction
J Lau et al. N Engl J Med. 1992.
Free article
Abstract
Background: The large volume of published randomized, controlled trials has led to a need for meta-analyses to track therapeutic advances. Performing a new meta-analysis whenever the results of a new trial of a particular therapy are published permits the study of trends in efficacy and makes it possible to determine when a new treatment appears to be significantly effective or deleterious. We describe the use of such a procedure, cumulative meta-analysis, to assess therapeutic trials among patients with myocardial infarction.
Methods: We performed cumulative meta-analyses of clinical trials that evaluated 15 treatments and preventive measures for acute myocardial infarction.
Results: An example of this method is its application to the use of intravenous streptokinase as thrombolytic therapy for acute infarction. Thirty-three trials evaluating this therapy were performed between 1959 and 1988. We found that a consistent, statistically significant reduction in total mortality (odds ratios, 0.74; 95 percent confidence interval, 0.59 to 0.92) was achieved in 1973, after only eight trials involving 2432 patients had been completed. The results of the 25 subsequent trials, which enrolled an additional 34,542 patients through 1988, had little or no effect on the odds ratio establishing efficacy, but simply narrowed the 95 percent confidence interval. In particular, two very large trials, the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico trial in 1986 (11,712 patients) and the Second International Study of Infarct Survival trial in 1988 (17,187 patients) did not modify the already established evidence of efficacy. We used a similar approach to study the accumulating evidence of efficacy (or lack of efficacy) of 14 other therapies and preventive measures for myocardial infarction.
Conclusions: Cumulative meta-analysis of therapeutic trials facilitates the determination of clinical efficacy and harm and may be helpful in tracking trials, planning future trials, and making clinical recommendations for therapy.
Comment in
- Clinical trials and meta-analysis. What do they do for us?
Kassirer JP. Kassirer JP. N Engl J Med. 1992 Jul 23;327(4):273-4. doi: 10.1056/NEJM199207233270411. N Engl J Med. 1992. PMID: 1614470 No abstract available. - ACE inhibitors after myocardial infarction.
Müller R, Steffen HM, Krone W. Müller R, et al. N Engl J Med. 1993 Apr 1;328(13):967; author reply 968-9. N Engl J Med. 1993. PMID: 8446154 No abstract available.
Similar articles
- [The prognostic role of the stress test in patients discharged alive after an acute myocardial infarct. From thrombolytic studies prior to GISSI-2. Grupo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Cavalli A, Pizzetti F, Aletto C, Slavich G, Di Marco G, Levantesi G, Rosselli P, Bechi S, Dalle Mule J, Di Gregorio D, et al. Cavalli A, et al. G Ital Cardiol. 1995 Feb;25(2):217-23. G Ital Cardiol. 1995. PMID: 7642027 Review. Italian. No abstract available. - The GISSI Study: further analysis. Italian Group for the Study of Streptokinase in Myocardial Infarction (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico, GISSI).
Franzosi MG, Mauri F, Pampallona S, Bossi M, Matta F, Farina ML, Tognoni G. Franzosi MG, et al. Circulation. 1987 Aug;76(2 Pt 2):II52-6. Circulation. 1987. PMID: 3301057 Clinical Trial. No abstract available. - Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
De Luca G, Biondi-Zoccai G, Marino P. De Luca G, et al. Ann Emerg Med. 2008 Dec;52(6):665-76. doi: 10.1016/j.annemergmed.2008.08.033. Ann Emerg Med. 2008. PMID: 19027496 Review.
Cited by
- Reporting quality of meta-analyses in acupuncture: Investigating adherence to the PRISMA statement.
Qin C, Ma H, Mandizadza OO, Xu X, Ji C. Qin C, et al. Medicine (Baltimore). 2024 Sep 27;103(39):e39933. doi: 10.1097/MD.0000000000039933. Medicine (Baltimore). 2024. PMID: 39331860 Free PMC article. - Actioning the findings of hard endpoint clinical trials as they emerge in the realm of chronic kidney disease care: a review and a call to action.
Strippoli GFM, Green SC. Strippoli GFM, et al. Clin Kidney J. 2024 Feb 9;17(2):sfae035. doi: 10.1093/ckj/sfae035. eCollection 2024 Feb. Clin Kidney J. 2024. PMID: 38425707 Free PMC article. Review. - Confidence score: a data-driven measure for inclusive systematic reviews considering unpublished preprints.
Tong J, Luo C, Sun Y, Duan R, Saine ME, Lin L, Peng Y, Lu Y, Batra A, Pan A, Wang O, Li R, Marks-Anglin A, Yang Y, Zuo X, Liu Y, Bian J, Kimmel SE, Hamilton K, Cuker A, Hubbard RA, Xu H, Chen Y. Tong J, et al. J Am Med Inform Assoc. 2024 Apr 3;31(4):809-819. doi: 10.1093/jamia/ocad248. J Am Med Inform Assoc. 2024. PMID: 38065694 - The burden and management strategies of hypertensive crisis in adult patients presenting to emergency departments of district and regional hospitals in Sub-Saharan Africa.
Kilindimo SS, Abdulkarim A, Simbila AN, Harrison R, Shirima L, Abdallah F, Mukhtar AG, Mfinanga J, Saika J, Kisanga E, Sawe HR. Kilindimo SS, et al. Clin Hypertens. 2023 Oct 1;29(1):27. doi: 10.1186/s40885-023-00251-8. Clin Hypertens. 2023. PMID: 37777812 Free PMC article. - Trends of Randomized Clinical Trials Citing Prior Systematic Reviews, 2007-2021.
Jia Y, Li B, Yang Z, Li F, Zhao Z, Wei C, Yang X, Jin Q, Liu D, Wei X, Yost J, Lund H, Tang J, Robinson KA. Jia Y, et al. JAMA Netw Open. 2023 Mar 1;6(3):e234219. doi: 10.1001/jamanetworkopen.2023.4219. JAMA Netw Open. 2023. PMID: 36951864 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical